Get started
Has Alcoa Bottomed?Alcoa has been falling since Thanksgiving, but some traders may think the aluminum stock has bottomed. The first pattern on today’s chart is the April 9 high of $26.67. AA was trapped under that level for a month but yesterday it closed above it for the first time. Is the old resistance broken? Second is the series of higher lows during the period of bottoming. Those may suggest buyers outnumber sellers. Third, the 8-day exponential moving average (EMA) is climbing toward the 21-day EMA. A crossover could indicate the short-term trend is getting bullish. MACD is also rising. Finally, AA is about 20 percent below its 200-day simple moving average. That may provide space for a rebound -- especially with lower tariffs easing worries about the economy. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options and futures. If you're born to trade, we could be for you. See our Overview for more. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options or futures); therefore, you should not invest or risk money that you cannot afford to lose. Online trading is not suitable for all investors. View the document titled Characteristics and Risks of Standardized Options at www.TradeStation.com . Before trading any asset class, customers must read the relevant risk disclosure statements on www.TradeStation.com . System access and trade placement and execution may be delayed or fail due to market volatility and volume, quote delays, system and software errors, Internet traffic, outages and other factors. Securities and futures trading is offered to self-directed customers by TradeStation Securities, Inc., a broker-dealer registered with the Securities and Exchange Commission and a futures commission merchant licensed with the Commodity Futures Trading Commission). TradeStation Securities is a member of the Financial Industry Regulatory Authority, the National Futures Association, and a number of exchanges. TradeStation Securities, Inc. and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., both operating, and providing products and services, under the TradeStation brand and trademark. When applying for, or purchasing, accounts, subscriptions, products and services, it is important that you know which company you will be dealing with. Visit www.TradeStation.com for further important information explaining what this means.
NYSE:AA
by TradeStation
Primoris Services: A Long-Term Pick in US Energy Infrastructure◉ Abstract Our latest analysis focuses on the booming U.S. utility and energy sector, set to hit a massive $1.1 trillion! Learn about the key drivers fueling this growth, from our increasing electricity needs and the electric vehicle revolution to the exciting rise of clean energy. We have also given a “Buy” rating on Primoris Services Corporation NYSE:PRIM , a major player in building this energy infrastructure. Our analysis reveals their strong financial performance, attractive valuation compared to its peers, and promising technical indicators. While acknowledging potential headwinds like regulatory shifts, we believe Primoris presents a compelling long-term investment opportunity with significant upside potential. Read detailed analysis here and invest smartly. Read full analysis here... ◉ Introduction Imagine the companies that bring electricity to your home, the gas for your stove, and are building the future of clean energy. That's the U.S. utility and energy sector! It's a massive part of the American economy, and it's getting even bigger. By 2025, experts predict it will be worth a whopping $1.1 trillion! This includes everything from generating electricity to delivering it through power lines and pipelines, as well as distributing natural gas across the country. This sector has been steadily growing at about 2.7% each year between 2020 and 2025, and it looks like this growth is going to continue. This article will give you a snapshot of the major reasons behind this growth, top players in this sector, and investment opportunities. ◉ Major Factors Behind the Growth of US Energy Sector 1. Electricity Use is Climbing: Americans are using more power than ever. The EIA expects electricity consumption to hit 4,205 Billion kWh in 2025, up from 4,097 Billion kWh in 2024. This surge is fuelled by increased usage in residential, commercial, and industrial sectors. 2. Everything’s Going Electric: Think about electric cars, heat pumps that heat and cool homes, and even cleaner machines in factories. More and more things are switching to electricity, which means we need even more power! This big shift towards using electricity is called electrification, and it's a major driver for the energy sector. 3. Clean Energy on the Rise: Solar panels and wind turbines are becoming a bigger part of how we get our electricity. These renewable energy sources are growing fast. By 2026, it's expected that they will provide about 27% of all the electricity in the U.S., up from around 25% in 2024. This move towards cleaner energy is really important for the future. 4. Massive Investments Ahead: To keep up with this growing demand and the shift to new technologies, utility companies are investing a lot of money. They are upgrading power grids (the network of lines that deliver electricity), building charging stations for electric vehicles (EVs), and using smart technologies to manage energy better. Experts at S&P Global predict that total spending on these things could be over $790 Billion between 2025 and 2030! ◉ Big Players in Building the US Energy Infrastructure 1. Quanta Services, Inc. NYSE:PWR : A premier provider of specialized infrastructure solutions for the electric power and oil & gas sectors. They are also heavily involved in renewable energy projects like solar and wind farms. You can learn more about them on their official website . 2. Primoris Services Corporation NYSE:PRIM : They provide construction and engineering services for the energy, utility, and infrastructure markets. They are increasingly focusing on building projects related to renewable energy. You can explore their details on their official website . 3. MasTec, Inc. NYSE:MTZ : This is a top infrastructure company in North America, working on energy, utility, and communication projects. This includes building renewable energy facilities, telecom networks, and oil & gas pipelines. You can find more information on their official website . This report offers an in-depth analysis of Primoris Services Corporation , a prominent player in the U.S. energy infrastructure space. Our long term recommendation is backed by Primoris Services Corporation ’s technical analysis and fundamental performance. ◉ Investment Advice 💡 Buy Primoris Services Corporation NYSE:PRIM ● Buy Range - 67 - 68 ● Sell Target - 88 - 90 ● Potential Return - 30% - 45% ● Approx Holding Period - 12-14 months ◉ Revenue and Profit Analysis ● Year-on-Year - In FY24, Primoris reported revenue of $6,367 Million, marking an 11% increase from $5,715 Million in FY23. - EBITDA grew to $415 Million, up from $366 Million the previous year, with the EBITDA margin slightly improving to 6.5% from 6.4%. ● Quarter-on-Quarter - Q4 FY24 revenue reached a record $1,741 Million, up from $1,649 Million in Q3 and 14.9% higher than $1,515 Million in Q4 FY23. - Despite the revenue growth, Q4 EBITDA declined to $110.6 Million from $123 Million in Q3. - Diluted EPS (LTM) rose to $3.30 in Q4, up from $3.00 in Q3 FY24, indicating solid earnings momentum. ◉ Valuation 1. P/E Ratio (Price-to-Earnings) ● Compared to Peers: - PRIM’s P/E is 17.9x, much lower than the peer average of 32.7x. This means the stock is cheaper than most competitors based on earnings. ● Compared to Industry: - With a P/E ratio of 17.9x, PRIM trades below the industry average of 26.4x, suggesting it offers strong value within the sector. 2. P/B Ratio (Price-to-Book) ● Compared to Peers: - PRIM’s P/B is 2.6x, while peers average 4.5x—again showing the stock may be undervalued. ● Compared to Industry: - Compared to the industry average of 4.4x, PRIM still appears to be a bargain. 3. PEG Ratio (Price/Earnings to Growth) PRIM’s PEG ratio is 0.43, which suggests the stock is not only cheap but also expected to grow earnings strongly—an attractive combination for investors. ◉ Cash Flow Analysis - Primoris saw a strong improvement in operating cash flow, which jumped to $508 Million in FY24 from $196.8 Million in FY23—a sign of better cash generation from its core business. ◉ Debt Analysis - With a debt-to-equity ratio of 0.42, the company maintains a solid financial position, suggesting its debt levels are well under control and not overly risky. ◉ Top Shareholders - The Vanguard Group holds a substantial 11.6% stake in Primoris, reflecting strong confidence in the company. - BlackRock also increased its investment by 9.65% from Q3 FY24 and now owns approximately 11.3% of the company. ◉ Technical Aspects - On the monthly chart, the price is in an overall uptrend and has bounced off the trendline support, indicating continued upward momentum. - On the daily chart, the price has broken through a rounding bottom pattern and is holding above the breakout zone, suggesting a potential for further upside movement. ◉ Potential Risks & Challenges 1. Regulatory Uncertainty: Ongoing concerns about global trade policies, tariffs, and regulatory changes, especially in the solar and battery storage markets, could impact future project economics and timing. 2. SG&A Expenses: Increased by $10.9 Million year-over-year, driven by higher personnel costs and $3.2 Million in severance expenses. 3. Energy Segment Backlog: Experienced a decrease due to the timing of new solar awards, potentially affecting future revenue visibility. ◉ Conclusion Primoris Services Corporation NYSE:PRIM stands out as a promising investment, backed by consistent growth, strong financials, and a strategic focus on renewable energy and infrastructure. Despite facing risks like regulatory changes and backlog fluctuations, its solid position in the U.S. energy sector—especially with increased demand for clean energy solutions—gives it a clear path forward. With a competitive valuation and support from major investors like Vanguard and BlackRock, Primoris is poised for sustainable growth, making it an attractive long-term opportunity for investors.
NYSE:PRIMLong
by NaranjCapital
A thank you gift to my supporters! OSCR chart (it's BEAUTIFUL)Again, thank you to everyone who follows, who supports, who gains anything from any of my analysis. Outside of my personal trading, you guys are what keep me so close and connected to the trading world and I appreciate that you're here to be on this journey with me! This is Oscar Healthcare - The chart speaks for itself. IPO'd in the SPAC doomsday's and found itself sitting in the $2-4 range for quite some time. I loaded up and this is one of my biggest all time winners (outside of REAL). They've subsequently proven themselves over and over again and found themselves sitting in the $20 range for a bit until Mr. Trump was elected president and the healthcare industry ran scared (for potentially good reason). But put aside that this was sitting at $12-13 for a while (extremely undervalued territory as the chart indicates). The algorithms on OSCR never disappoint and it all comes down to one pretty little color called PURPLE! Watch this video and you'll understand the beauty of this chart and the workings of the market. Happy Trading all :)
NYSE:OSCRLong
by ReigningTrades
1
Amazon (AMZN) shares jump more than 7%Amazon (AMZN) shares jump more than 7% As shown in the Amazon (AMZN) share chart, the price surged by over 7% yesterday, breaking above the key psychological level of $200 and closing at its highest point since early March. The sharp rise in demand was driven by reports of a trade truce between the US and China following talks in Geneva. According to Reuters, the US has decided to lower the “de minimis” threshold on goods from China. This move could help de-escalate a potentially damaging trade war between the world’s two largest economies. For AMZN stock, this is a bullish signal, as Amazon sells a wide range of low-cost Chinese goods. Technical analysis of Amazon (AMZN) shares From a bearish perspective, the AMZN price has recovered to the 0.618 Fibonacci retracement level after falling from an all-time high to the early April low. In this context, selling pressure may re-emerge with the intention of resuming the downtrend—especially as most oscillators on the chart are signalling strong overbought conditions. From a bullish perspective: → The pattern of higher highs and higher lows in late April and early May may have outlined the median of an ascending channel; → Yesterday’s price surge in AMZN shares may point to the channel’s upper boundary. Given these conditions, it is reasonable to expect a minor pullback before the Amazon’s stock price resumes its upward trajectory within the blue channel. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
NASDAQ:AMZN
by FXOpen
1
META Pullback or Correction? Let’s Talk. Back in January 2025, META printed what looked like a top… but if you zoom out and analyze the structure, you’ll notice this wasn’t a true correction — just a healthy pullback. ✅ Price never broke critical structure ✅ Buyers stepped in at the 0.5–0.618 zone ✅ Current candle strength suggests bulls still in control This isn’t random. It’s structure. And structure tells me that META is gearing up for a potential new high — especially if we clear the Jan '25 zone around 740. Not financial advice, just what the charts are saying 🔍📊
NASDAQ:METALong
by MoNi_MoN
MercadoLibre setting up for good buy opportunityHello, MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. TECHNICAL ANALYSIS- Checklist 1. Structure drawing (Trend line drawing on past price chart data)- As shown below 2. Patterns identification (Naming patterns on past price chart data for future wave)- The stock is currently correcting & forming a bullish expanding triangle. 3. Future indication (Reading indicator for future wave)- 0 crossover about to happen 4. Future wave (Drawing on future price chart using future indication from indicator)- As shown below 5. Future reversal point (Identifying trend reversal point on price chart using structure)- Target point as shown From 2018 to 2023, the company experienced significant growth in its financial metrics. Total revenue rose from $1.44 billion in 2018 to $14.47 billion in 2023. Gross profit increased from $655.55 million in 2018 to $6.95 billion in 2023. Net income shifted from a loss of $36.59 million in 2018 to a profit of $987 million in 2023. The company’s earnings per share (EPS) improved from -$0.82 in 2018 to $19.35 in 2023. Total assets grew from $2.24 billion in 2018 to $17.65 billion in 2023, while total liabilities increased from $1.90 billion in 2018 to $14.58 billion in 2023. Highlights of the Nine months ended September 30th 2024 net revenue and financial income reached $14.718 billion, a significant increase from $10.698 billion in the same period of 2023. Gross Profit: Gross profit rose to $6.828 billion for the nine months ended September 30, 2024, compared to $5.540 billion in the same period of 2023. Net Income: Net income surged to $1.272 billion for the nine months ended September 30, 2024, up from $0.822 billion in the same period of 2023. Earnings Per Share (EPS): Basic earnings per share as of September 30, 2024, stood at $25.09. Total Current Assets: As of September 30, 2024, total current assets were $17.824 billion, up from $14.294 billion as of September 30, 2023. Total Current Liabilities: Total current liabilities as of September 30, 2024, increased to $4.308 billion, compared to $3.278 billion as of September 30, 2023. Opportunities The rising adoption of digital payments and growing preference for online shopping reinforce a strong, long-term growth trajectory for MercadoLibre. Expanding its first-party sales business enables MercadoLibre to better compete during major holiday seasons by offering strategic discounts on flagship products. Providing consumer and small-business loans addresses critical gaps in traditional financial services while fostering stronger ties between merchants, customers, and the MercadoLibre platform. Risks to consider Intense competition among fintech rivals may lead to slower-than-anticipated growth or reduced net interest margins for Mercado Pago's consumer, merchant, and credit card product lines. Escalating macroeconomic challenges in Argentina could heighten foreign exchange losses or, in extreme scenarios, disrupt the market entirely. Unique linguistic, trade, and cultural differences in the region pose challenges for cross-border sales, necessitating the upkeep of distinct marketplace platforms in each country. Our recommendation MercadoLibre’s profitability missed expectations, but the company’s focus on strengthening its competitive position is encouraging. Key areas like its logistics network (Mercado Envios), growing ads business, and new Prime-like program (Meli Mais) continue to improve. Despite slight underperformance, strong growth in consumer credit and a better business environment in Argentina are positives. With $6.7 billion in cash and a $400 million credit facility, MercadoLibre is financially strong. Shares remain slightly expensive, but the current correction could present a buying opportunity around the $1,850 level. Our recommendation is a wait to buy at around $1,850 with a target of $2,600. Current price: $1952 (3rd December, 2024)
NASDAQ:MELILong
by thesharkke
1
ImmunityBio: Catalyst for a New Era?ImmunityBio, Inc. is rapidly emerging as a significant force in the biotechnology sector, propelled by the success and expanding potential of its lead immunotherapy asset, ANKTIVA® (nogapendekin alfa inbakicept-pmln). The company achieved a pivotal milestone with the FDA approval of ANKTIVA in combination with BCG for treating BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ. This approval addresses a critical need and leverages ANKTIVA's unique mechanism as a first-in-class IL-15 agonist, designed to activate key immune cells and induce durable responses. Building on this success, ImmunityBio is actively pursuing global market access, submitting applications to the EMA and MHRA for potential approval in Europe and the UK by 2026. Beyond regulatory progress, ImmunityBio proactively tackles challenges in patient care, notably addressing the U.S. shortage of TICE® BCG. Through an FDA-authorized Expanded Access Program, the company supplies recombinant BCG (rBCG), providing a vital alternative source and expanding treatment access, particularly in underserved areas. This initiative supports patients and establishes a new market channel for ImmunityBio's therapies. Commercially, ANKTIVA's U.S. launch gains momentum, facilitated by a permanent J-code that simplifies billing and broadens insurance coverage, reaching over 240 million lives. ImmunityBio's strategic vision extends to other major cancer types. The company is advancing ANKTIVA's potential in non-small cell lung cancer (NSCLC) through a confirmatory Phase 3 trial with BeiGene. This collaboration follows promising Phase 2 data demonstrating ANKTIVA's ability to rescue checkpoint inhibitor activity in patients who have progressed on prior therapies, showing prolonged overall survival. This highlights ANKTIVA's broader potential as a foundational cytokine therapy capable of addressing lymphopenia and restoring immune function across various tumors. ImmunityBio's recent financial performance reflects this clinical and commercial traction, marked by a significant revenue increase driven by ANKTIVA sales and positive investor sentiment.
NASDAQ:IBRXLong
by UDIS_View